The role of HGF/c-MET signaling pathway in lymphoma.

The role of HGF/c-MET signaling pathway in lymphoma.
复制标题

HGF/c-MET信号通路在淋巴瘤中的作用

DOI:
10.1186/s13045-016-0366-y
复制
发表时间:
2016-12-07
影响因子:
28.5
通讯作者:
Qin Z
Qin Z
中科院分区:
医学1区
文献类型:
--
作者:
Lam BQ;Dai L;Qin Z

文献摘要

参考文献

被引文献

相似文献

肝细胞生长因子(HGF)的受体酪氨酸激酶(RTK)c-间充质-上皮转化蛋白(MET)的异常激活与肿瘤的发生密切相关,是开发抗癌药物的良好靶点。与其他实体瘤相比,有关HGF/c-Met信号通路在淋巴瘤中的功能作用的数据有限。现就HGF/c-MET在不同类型的淋巴瘤,特别是B细胞淋巴瘤、T细胞和NK细胞淋巴瘤以及霍奇金淋巴瘤中的表达、细胞机制/功能及其治疗应用的最新研究进展作一综述。我们还讨论了淋巴瘤细胞中HGF/c-MET通路研究中存在的问题和未来的研究方向。
Inappropriate activation of c-mesenchymal-epithelial transition (MET), the receptor tyrosine kinase (RTK) for hepatocyte growth factor (HGF), has been implicated in tumorigenesis and represented a promising therapeutic target for developing anticancer agents. In contrast to other solid tumors, there are limited data describing the functional role of HGF/c-MET signaling pathway in lymphoma. In the current review, we summarize recent findings about the expression, cellular mechanisms/functions, and therapeutic application of HGF/c-MET in different types of lymphoma, especially B cell lymphoma, T and NK cell lymphoma, and Hodgkin lymphoma. We also discuss the existing problems and future directions about studying the HGF/c-MET pathway in lymphoma cells.
DOI: 10.5045/br.2013.48.2.121
发表时间: 2013-06
期刊: Blood research
影响因子: 2.2
作者:
Bedewy M;El-Maghraby S;Bedewy A
通讯作者: Bedewy A
DOI: 10.1038/modpathol.2013.64
发表时间: 2013-09-01
期刊: MODERN PATHOLOGY
影响因子: 7.5
作者:
Koh, Young Wha;Park, Chansik;Huh, Jooryung
通讯作者: Huh, Jooryung
DOI: 10.1073/pnas.0403390101
发表时间: 2004-07-20
影响因子: 11.1
作者:
Menendez, JA;Vellon, L;Lupu, R
通讯作者: Lupu, R
DOI: 10.1634/theoncologist.2014-0241
发表时间: 2014-10-01
期刊: ONCOLOGIST
影响因子: 5.8
作者:
Kazandjian, Dickran;Blumenthal, Gideon M.;Pazdur, Richard
通讯作者: Pazdur, Richard
DOI: 10.1634/theoncologist.12-5-569
发表时间: 2007-01-01
期刊: ONCOLOGIST
影响因子: 5.8
作者:
Chen, Yi-Bin;Rahemtullah, Aliyah;Hochberg, Ephraim
通讯作者: Hochberg, Ephraim